Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MaxLinear, Inc.'s SEC filings document its public-company disclosures as a semiconductor issuer focused on RF, analog, digital and mixed-signal integrated circuits. Recent 8-K filings cover quarterly operating results, material agreements, credit-facility amendments, share repurchase authorization and governance changes.
Proxy materials describe board structure, director elections, committee service, executive compensation, equity awards and shareholder voting matters. The filing record also reflects capital-structure items tied to common stock, revolving credit arrangements, subsidiary participation in financing agreements and the risk and governance disclosures associated with MaxLinear’s operating business.
MaxLinear, Inc. reported a change in its independent auditor. Effective May 28, 2026, the company dismissed Grant Thornton LLP as its independent registered public accounting firm, with approval from the board’s audit committee, and appointed KPMG LLP for the fiscal year ending December 31, 2026.
Grant Thornton’s audit reports on MaxLinear’s consolidated financial statements for the years ended December 31, 2025 and 2024 contained no adverse opinions, disclaimers, or qualifications. The company states there were no disagreements with Grant Thornton and no reportable events under Regulation S-K during those periods.
MAXLINEAR, INC director Thomas E. Pardun reported an insider transaction involving common stock. On May 26, 2026, the Thomas E. Pardun Irrevocable Trust, an entity associated with him, completed an open-market sale of 11,000 common shares at $105 per share.
Following this sale, the trust held 55,252 common shares indirectly, while Pardun also held 12,141 common shares directly. The filing reflects a net reduction of 11,000 shares in his reported holdings, combining both direct and indirect positions disclosed.
MaxLinear, Inc. Corporate Controller & PAO Connie H. Kwong reported routine equity compensation activity involving restricted stock units (RSUs). On May 25, 2026, 3,713 RSUs converted into an equal number of common shares, and the company withheld 3,713 shares to cover tax obligations. After these transactions, she directly held 22,069 shares of common stock. Footnotes clarify this was related to previously deferred RSU vesting and was not an open-market trade.
MaxLinear director Albert J. Moyer exercised previously deferred equity awards into common stock. On May 20, 2026, he converted 40,336 restricted stock units (RSUs) into an equal number of MaxLinear common shares, reflecting the settlement of RSUs that each represent a contingent right to one share.
The footnotes explain that Moyer had deferred settlement of these RSUs until he left the board or a qualifying change in control. His retirement from the board on May 20, 2026 triggered this settlement, and he now holds 113,129 common shares directly. No open-market purchases or sales are reported in this filing.
Sennesael Kris reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Kris Sennesael received a grant of 1,963 restricted stock units. Each RSU represents a contingent right to receive one share of MaxLinear common stock.
The RSUs will fully vest on the earlier of May 1, 2027 or the date immediately before the next annual stockholder meeting, as long as Sennesael continues serving as a director.
ARTUSI DANIEL A reported acquisition or exercise transactions in this Form 4 filing.
MaxLinear director Daniel A. Artusi received a new equity award in the form of restricted stock units. On May 20, 2026, he was granted 1,963 RSUs, each representing a contingent right to receive one share of MaxLinear common stock. Following this grant, his reported derivative holdings from this filing consist of these 1,963 RSUs.
The award will vest 100% on the earlier of May 1, 2027 or the date immediately preceding MaxLinear’s next annual meeting of stockholders, provided he continues to serve as a Director under the company’s 2010 Equity Incentive Plan.
Tewksbury Ted L III reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC reported that director Ted L. Tewksbury III received a grant of 1,963 Restricted Stock Units. Each RSU represents a contingent right to receive one share of MaxLinear common stock. The RSUs will vest 100% on the earlier of May 1, 2027 or the date immediately preceding the next annual meeting of stockholders, as long as he continues serving as a director.
PARDUN THOMAS E reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Thomas E. Pardun received a grant of 1,963 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of MaxLinear common stock as equity compensation rather than an open-market purchase.
All 1,963 RSUs will vest in a single installment, subject to Pardun continuing to serve as a director, on the earlier of May 1, 2027 or the date immediately preceding MaxLinear’s next annual meeting of stockholders. Following this award, Pardun holds 1,963 RSUs directly.
Dougherty Greg reported acquisition or exercise transactions in this Form 4 filing.
MAXLINEAR, INC director Greg Dougherty received an equity award in the form of 1,963 restricted stock units (RSUs). Each RSU represents a right to receive one share of MaxLinear common stock. The entire award is scheduled to vest on May 1, 2027, or immediately before the next annual stockholder meeting, provided he continues serving as a director.